PURExpress® Δ Ribosome Kit

Catalog # Concentration Size List Price Quantity Your Price
E3313S 10 reactions $570.00
$513.00
Catalog # Size List Price Your Price
E3313S 10 reactions $570.00
$513.00
Catalog #
Qty:
 
*On-line ordering is for Canadian customers only. Web pricing is applicable only to orders placed online at www.neb.ca

PURExpress® delta ribosome kit is a variation of the PURExpress In vitro Protein Synthesis Kit where ribosomes are omitted from the translation mix.

  • Control ribosomes provided separately
  • Designed for use with your own ribosomes
  • User supplied ribosomes can be E. coli-based wild type, mutant or ribosome from other bacterial species
  • Convenient for directly assaying ribosomal activity and translation studies
A rapid method for gene expression analysis, PURExpress® is a novel cell-free transcription/translation system reconstituted from the purified components necessary for E. coli translation. With minimal nuclease and protease activity, the PURExpress system preserves the integrity of DNA and RNA templates/complexes and results in proteins that are free of modification and degradation. Transcription and translation are carried out in a one-step reaction, and require the mixing of only two tubes. With results available in a few hours, PURExpress saves valuable laboratory time and is ideal for high throughput technologies.

PURExpress Citations


Figure 1: Protein expression using the PURExpress® In Vitro Protein Synthesis Kit Figure 1: Protein expression using the PURExpress® In Vitro Protein Synthesis Kit.
25 μl reactions containing 250 ng template DNA and 20 units RNase Inhibitor were incubated at 37°C for 2 hours. 2.5 μl of each reaction was analyzed by SDS-PAGE using a 10–20% Tris-glycine gel. The red dot indicates the protein of interest. Marker M is the Protein Ladder (NEB #P7703, discontinued and replaced with NEB #P7717).
Figure 2: Incorporation of 35S-methionine enables visualizationof protein by autoradiography Figure 2: Incorporation of 35S-methionine enables visualizationof protein by autoradiography
25 μl reactions containing 250 ng template DNA, 20 units RNase Inhibitor and 2 μl 35S-met were incubated at 37°C for 2 hours. 2.5 μl of each reaction was analyzed by SDS-PAGE, the gel was fixed for 10 minutes, dried for 2 hours at 80°C and exposed to x-ray film for 5 hours at -80°C.
Figure 3: Schematic diagram of protein synthesis and purification by PURExpressFigure 3: Schematic diagram of protein synthesis and purification by PURExpress

Figure 4: Expression and reverse purification of DHFR (A) and T4 DNA Ligase (B) using PURExpress Figure 4: Expression and reverse purification of DHFR (A) and T4 DNA Ligase (B) using PURExpress
125 μl reactions were carried out according to recommendations in the accompanying manual. Samples were analyzed on a 10–20% Tris-glycine gel and stained with Coomassie Blue. Note that in both cases, the desired protein can be visualized in the total protein fraction. The red dot indicates the protein of interest. Marker M is the Protein Ladder (NEB #P7703, discontinued and replaced with NEB #P7717 ).
Highlights
  • Cleaner System - sample degradation eliminated
  • Easy-to-use - protein expression complete in approximately two hours
  • Simple Analysis - protein can often be visualized directly on a Coomassie stained gel
Reagents Supplied

The following reagents are supplied with this product:

NEB # Component Name Component # Stored at (°C) Amount Concentration
  Solution A (E3313) B0231AVIAL -80 1 x 0.1 ml 2.5 X
  Factor Mix (30 μl) P0762AVIAL -80 1 x 0.03 ml
  E. coli Ribosome P0763AVIAL -80 1 x 0.01 ml 13.3 µM
  PURExpress Control DHFR Plasmid N0424AVIAL -20 1 x 0.01 ml 125 ng/µl
Application Features
  • Quickly generate analytical amounts of protein for further characterization
  • Confirmation of open reading frames
  • Examination of the effects of mutations on ORFs
  • Generation of truncated proteins to identify active domains and functional residues
  • Introduction of modified, unnatural or labeled amino acids
  • Epitope mapping
  • Expression of toxic proteins
  • Ribosome display
  • Translation and/or protein folding studies
  • In vitro compartmentalization

Properties & Usage

Materials Required but not Supplied

General: 37°C incubator

Labeling: 35S-Methionine (>1000 Ci/mmol recommended, in vitro translation grade)

TCA Precipitation: TCA solutions (25%, 10%), 1 M NaOH, casamino acids, ethanol, glass fiber filters, vacuum filtration manifold
 
SDS-PAGE: Gels and running buffer, gel apparatus, power supply, gel dryer

Western Blotting: Transfer apparatus, membrane, antibodies and detection reagent

Purification: Ni-NTA Agarose, Amicon Ultra- 0.5 ml, Ultracel- 100K Membrane Centrifugal Filters

Notes
  • The DHFR control template is now supplied at 125 ng/µl. Use 2 µl for the positive control reaction. We use 60 pmoles of ribosomes in a standard 25 μl reaction. The supplied control ribosomes are enough for two reactions. Note: Using a smaller amount of ribosomes is possible but the protein yield may be lower.  For detailed usage information please refer to the product manual.
  • PURExpress Control Template sequence files: Fasta, GenBank
  • Storage: All kit components should be stored at -80°C.
References
  • Gupta, P., K. Kannan, et al. (2013). Regulation of Gene Expression by Macrolide-Induced Ribosomal Frameshifting. Mol Cell. 52(5), 629-42. PubMedID: 24239289
  • Tsai, A., J. Chen, et al. (2013). Observing Prokaryotic Translation Elongation in Real-Time using Single-Molecule Fluorescence. Biophysical Journal. 104(2, Supplement 1), 257a.
  • Vazquez-Laslop, N., H. Ramu, et al. (2010). The key function of a conserved and modified rRNA residue in the ribosomal response to the nascent peptide. EMBO J. 29(18), 3108-3117. PubMedID: 20676057
  • Vázquez-Laslop, N., H. Ramu, et al. (2011). Nascent peptide-mediated ribosome stalling promoted by antibiotics. Ribosomes. 377-392.
  • Gupta, P., S. Sothiselvam, et al. (2013). Deregulation of translation due to post-transcriptional modification of rRNA explains why erm genes are inducible. Nat Commun . 4, 1984. PubMedID: 23749080
  • Harvey, C. J., J. D. Puglisi, et al. (2012). Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: selectivity in the ribosome macrolide binding pocket. J Am Chem Soc. 134(29), 12259-65. PubMedID: 22741553
  • Kaiser, C. M., D. H. Goldman, et al. (2011). The ribosome modulates nascent protein folding. Science. 334(6063), 1723-7. PubMedID: 22194581
  • Kannan, K., N. Vázquez-Laslop, et al. (2012). Selective Protein Synthesis by Ribosomes with a Drug-Obstructed Exit Tunnel. Cell. 151(3), 508-520. PubMedID: 23101624
  • Kopaskie, K. S., K. G. Ligtenberg, et al. (2013). Translational regulation of Yersinia enterocolitica mRNA encoding a type III secretion substrate. Journal of Biological Chemistry. 288(49), 35478-88. PubMedID: 24158443
  • Martínez, A. K., E. Gordon, et al. (2013). Interactions of the TnaC nascent peptide with rRNA in the exit tunnel enable the ribosome to respond to free tryptophan. Nucleic Acids Research. 42(2), 1245-56. PubMedID: 24137004
  • Orelle, C., S. Carlson, et al. (2013). Tools for Characterizing Bacterial Protein Synthesis Inhibitors. Antimicrob Agents Chemother. 57(12), 5994-6004. PubMedID: 24041905
  • Shi, W., X. Zhang, et al. (2011). Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science. 333(6049), 1630-1632. PubMedID: 21835980
Tech Tips
  • Thaw and assemble reactions on ice
    Thoroughly mix solutions A and B before using. Do not vortex Solution B or ribosomes, mix gently.
    Solution A may have a cloudy white appearance. Add to the reaction as a uniform suspension.
    Assemble the reactions in the following order on ice: Solution A, Solution B, RNAse Inhibitor, Water, Template DNA or RNA
    Once reaction is assembled take time to make sure everything is thoroughly mixed by gently pipetting up and down, pulse spin and place at 37C for 2 to 4 hours.
Quality Control Assay
Quality Control tests are performed on each new lot of NEB product to meet the specifications designated for it. Specifications and individual lot data from the tests that are performed for this particular product can be found and downloaded on the Product Specification Sheet, Certificate of Analysis, data card or product manual. Further information regarding NEB product quality can be found here.
Specifications
The Specification sheet is a document that includes the storage temperature, shelf life and the specifications designated for the product. The following file naming structure is used to name these document files: [Product Number]_[Size]_[Version]
Legal And Disclaimer

Products and content are covered by one or more patents, trademarks and/or copyrights owned or controlled by New England Biolabs, Inc (NEB). The use of trademark symbols does not necessarily indicate that the name is trademarked in the country where it is being read; it indicates where the content was originally developed. The use of this product may require the buyer to obtain additional third-party intellectual property rights for certain applications. For more information, please email busdev@neb.com.

This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.

New England Biolabs (NEB) is committed to practicing ethical science – we believe it is our job as researchers to ask the important questions that when answered will help preserve our quality of life and the world that we live in. However, this research should always be done in safe and ethical manner. Learn more.PURExpress® is based on the PURE System Technology originally developed by Dr. Takuya Ueda at the University of Tokyo and commercialized as the PURESYSTEM® by BioComber (Tokyo, Japan).

Licensed from BioComber (Tokyo, Japan) under Patent Nos. 7,118,883; WO2005-105994 and JP2006-340694. For research use only. Commercial use of PURExpress® In vitro Protein Synthesis Kit requires a license from New England Biolabs, Inc. This product is intended for research purposes only. This product is not intended to be used for therapeutic or diagnostic purposes in humans or animals. 

Top